Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells

Liu,Shihai; Liu,Xiangping; Wang,Haibo; Zhou,Quan; Liang,Ye; Sui,Aihua; Yao,Ruyong; Zhao,Bin; Sun,Ming

doi:10.3892/or.2015.3872

Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells

Authors:
- Shihai Liu
- Xiangping Liu
- Haibo Wang
- Quan Zhou
- Ye Liang
- Aihua Sui
- Ruyong Yao
- Bin Zhao
- Ming Sun
View Affiliations

Affiliations: Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China, Center of Diagnosis and Treatment of Breast Disease, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China
Published online on: March 20, 2015 https://doi.org/10.3892/or.2015.3872
Pages: 2477-2483

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Triple-negative breast cancer (TNBC), characterized by distinct biological and clinicopathological features, has a poor prognosis due to lack of effective therapeutic targets. Our previous data revealed that high levels of USP39 were selectively present in TNBC samples compared with their normal breast tissue samples and USP39 was also expressed at different levels in cultured TNBC cells and normal breast cells. Yet, the underlying cellular and molecular mechanisms of USP39 remain unclear. In the present study, we describe a doxycycline (DOX)-regulated lentiviral vector system expressing shRNA or cDNA of the USP39 gene in the TNBC cell line MDA-MB-231. USP39 expression was knocked down by the miR-30-based inducible lentiviral short hairpin RNA (shRNA) delivery system or overexpressed by the inducible cDNA system. The inducible shRNA-mediated downregulation of USP39 expression markedly reduced the proliferation and colony-forming ability of MDA-MB-231 cells, while overexpression of USP39 by the inducible system did not promote cancer cell proliferation. The lentiviral vector-mediated Tet-on system demonstrated efficient and inducible knockdown of USP39 or overexpression of USP39 in TNBC cells, facilitating a wide variety of applications for gene knockdown and overexpression experiments in gene functional studies in vitro and in vivo.

View Figures

View References

1	Shin HR, Carlos MC and Varghese C: Cancer control in the Asia Pacific region: current status and concerns. Jpn J Clin Oncol. 42:867–881. 2012. View Article : Google Scholar : PubMed/NCBI
2	Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
3	Foulkes WD, Smith IE and Reis-Filho JS: Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010. View Article : Google Scholar : PubMed/NCBI
4	Ferguson LL, Curran B, Martinez M, et al: Triple-negative breast cancer: what is known about it? Clin J Oncol Nurs. 18:E6–E11. 2014. View Article : Google Scholar : PubMed/NCBI
5	Hirshfield KM and Ganesan S: Triple-negative breast cancer: molecular subtypes and targeted therapy. Curr Opin Obstet Gynecol. 26:34–40. 2014. View Article : Google Scholar
6	Gangi A, Chung A, Mirocha J, et al: Breast-conserving therapy for triple-negative breast cancer. JAMA Surg. 149:252–258. 2014. View Article : Google Scholar : PubMed/NCBI
7	Chin YR, Yoshida T, Marusyk A, et al: Targeting Akt3 signaling in triple-negative breast cancer. Cancer Res. 74:964–973. 2014. View Article : Google Scholar :
8	Dikic I, Wakatsuki S and Walters KJ: Ubiquitin-binding domains - from structures to functions. Nat Rev Mol Cell Biol. 10:659–671. 2009. View Article : Google Scholar : PubMed/NCBI
9	Pickart CM and Eddins MJ: Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta. 1695:55–72. 2004. View Article : Google Scholar : PubMed/NCBI
10	Makarova OV, Makarov EM and Luhrmann R: The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes. EMBO J. 20:2553–2563. 2001. View Article : Google Scholar : PubMed/NCBI
11	van Leuken RJ, Luna-Vargas MP, Sixma TK, et al: Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B. Cell Cycle. 7:2710–2719. 2008. View Article : Google Scholar : PubMed/NCBI
12	Rios Y, Melmed S, Lin S, et al: Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion. PLoS Genet. 7:e10012712011. View Article : Google Scholar : PubMed/NCBI
13	Song EJ, Werner SL, Neubauer J, et al: The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. Genes Dev. 24:1434–1447. 2010. View Article : Google Scholar : PubMed/NCBI
14	Luna-Vargas MP, Faesen AC, van Dijk WJ, et al: Ubiquitin-specific protease 4 is inhibited by its ubiquitin-like domain. EMBO Rep. 12:365–372. 2011. View Article : Google Scholar : PubMed/NCBI
15	Gossen M and Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA. 89:5547–5551. 1992. View Article : Google Scholar : PubMed/NCBI
16	Gossen M, Freundlieb S, Bender G, et al: Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1766–1769. 1995. View Article : Google Scholar : PubMed/NCBI
17	Kao J, Salari K, Bocanegra M, et al: Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One. 4:e61462009. View Article : Google Scholar : PubMed/NCBI
18	Wang H, Ji X, Liu X, et al: Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro. Oncol Rep. 30:2871–2877. 2013.PubMed/NCBI
19	Wang H, Zhao G, Liu X, et al: Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo. J Exp Clin Cancer Res. 29:1232010. View Article : Google Scholar : PubMed/NCBI
20	Butt AJ, Dickson KA, McDougall F, et al: Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem. 278:29676–29685. 2003. View Article : Google Scholar : PubMed/NCBI
21	McIlroy D, Sakahira H, Talanian RV, et al: Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli. Oncogene. 18:4401–4408. 1999. View Article : Google Scholar : PubMed/NCBI
22	Pegram MD, Lipton A, Hayes DF, et al: Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol. 16:2659–2671. 1998.PubMed/NCBI
23	Carey LA, Dees EC, Sawyer L, et al: The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res. 13:2329–2334. 2007. View Article : Google Scholar : PubMed/NCBI
24	Haffty BG, Yang Q, Reiss M, et al: Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 24:5652–5657. 2006. View Article : Google Scholar : PubMed/NCBI
25	Bauer M, Kinkl N, Meixner A, et al: Prevention of interferon-stimulated gene expression using microRNA-designed hairpins. Gene Ther. 16:142–147. 2009. View Article : Google Scholar
26	Sun BS, Dong QZ, Ye QH, et al: Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology. 48:1834–1842. 2008. View Article : Google Scholar : PubMed/NCBI
27	Stegmeier F, Hu G, Rickles RJ, et al: A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci USA. 102:13212–13217. 2005. View Article : Google Scholar : PubMed/NCBI
28	Boden D, Pusch O, Silbermann R, Lee F, Tucker L and Ramratnam B: Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res. 32:1154–1158. 2004. View Article : Google Scholar : PubMed/NCBI
29	Snyder LL, Esser JM, Pachuk CJ, et al: Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts. Antiviral Res. 80:36–44. 2008. View Article : Google Scholar : PubMed/NCBI
30	Liu XY, Tang QS, Chen HC, et al: Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity. Int J Biol Sci. 9:564–577. 2013. View Article : Google Scholar : PubMed/NCBI
31	Lee Y, Kim M, Han J, et al: MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23:4051–4060. 2004. View Article : Google Scholar : PubMed/NCBI
32	Lygerou Z, Christophides G and Seraphin B: A novel genetic screen for snRNP assembly factors in yeast identifies a conserved protein, Sad1p, also required for pre-mRNA splicing. Mol Cell Biol. 19:2008–2020. 1999.PubMed/NCBI